Cocrystal Pharma's market cap is currently $19.94M. The company's EPS TTM is $-1.838; its P/E ratio is ―; Cocrystal Pharma is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 2.01M	$ 6.56M
Gross Profit	$ -15.17M	$ -241.60K	$ -239.50K	$ 1.78M	$ 6.56M
Operating Income	$ -18.56M	$ -38.83M	$ -14.22M	$ -9.59M	$ -48.41M
EBITDA	$ -19.37M	$ -38.45M	$ -13.80M	$ -9.30M	$ -47.90M
Net Income	$ -17.98M	$ -38.84M	$ -14.19M	$ -9.66M	$ -48.19M
Balance Sheet
Cash & Short-Term Investments	$ 26.35M	$ 37.14M	$ 58.70M	$ 33.01M	$ 7.42M
Total Assets	$ 31.26M	$ 40.84M	$ 79.39M	$ 54.24M	$ 28.53M
Total Debt	$ 1.85M	$ 297.00K	$ 534.00K	$ 596.00K	$ 817.00K
Net Debt	$ -24.50M	$ -36.85M	$ -58.17M	$ -32.41M	$ -6.60M
Total Liabilities	$ 4.88M	$ 1.27M	$ 1.84M	$ 1.74M	$ 2.82M
Stockholders' Equity	$ 26.38M	$ 39.57M	$ 77.55M	$ 52.51M	$ 25.71M
Cash Flow
Free Cash Flow	$ -14.78M	$ -21.51M	$ -12.77M	$ -10.07M	$ -1.71M
Operating Cash Flow	$ -14.67M	$ -21.43M	$ -12.72M	$ -9.83M	$ -1.56M
Investing Cash Flow	$ -118.00K	$ -74.00K	$ -52.00K	$ -240.00K	$ -145.00K
Financing Cash Flow	$ 3.99M	$ -27.00K	$ 38.47M	$ 35.66M	$ 6.42M

Currency in USD

Cocrystal Pharma Earnings and Revenue History

Income Statement >

Cocrystal Pharma Debt to Assets

Balance Sheet >

Cocrystal Pharma Cash Flow

Cash Flow >

Cocrystal Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing